{
    "clinical_study": {
        "@rank": "84063", 
        "arm_group": [
            {
                "arm_group_label": "Nut group", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects were supplemented with 30 g of mixed nuts including walnuts, peanuts, and pine nuts for 6 weeks"
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "Control group maintained their usual diet without nut supplement"
            }
        ], 
        "brief_summary": {
            "textblock": "This study aimed to investigate the effects of nut consumption on metabolic parameters and\n      biomarkers related to inflammation, oxidative stress, and endothelial function in Korean\n      adults with metabolic syndrome."
        }, 
        "brief_title": "Effects of Nut Consumption on Metabolic Syndrome", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Metabolic Syndrome", 
        "condition_browse": {
            "mesh_term": "Metabolic Syndrome X"
        }, 
        "detailed_description": {
            "textblock": "A randomized, controlled, parallel, dietary intervention study was designed. Subjects with\n      metabolic syndrome and body mass index \u226523 kg/m2 were randomized to the Nut group, which\n      were supplemented with 30 g of mixed nuts including walnuts, peanuts, and pine nuts for 6\n      weeks; or allocated to the Control group. Metabolic markers were evaluated at baseline and\n      at the end of the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects were enrolled if their body mass index (BMI) was \u226523 kg/m2 and they met the\n             criteria for metabolic syndrome.\n\n        Exclusion Criteria:\n\n          -  Subjects were excluded if they had a nut allergy, peptic disorder, a history of\n             cancer or cardiovascular disease including coronary artery disease, heart valve\n             disease, or stroke, or established chronic diseases such as chronic renal\n             insufficiency or cirrhosis. Subjects were also excluded if they:1) were receiving\n             treatment with hypoglycemic agents for diabetes or had HbA1c >7%; 2) were receiving\n             corticosteroid treatment; 3) had started antihypertensive or lipid-lowering agents,\n             or changed their doses within the previous month; 4) had a weight change \u22655 % of body\n             weight during the three months prior to the study; 5) were pregnant; or 6) were\n             regular nut consumers (>15g/day of nuts at least three times a week)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02023749", 
            "org_study_id": "12161MFDS118", 
            "secondary_id": "12161MFDS118"
        }, 
        "intervention": {
            "arm_group_label": "Nut group", 
            "intervention_name": "Nut group", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "nuts", 
            "metabolic syndrome", 
            "lipid profile", 
            "inflammation", 
            "oxidative stress", 
            "endothelial function"
        ], 
        "lastchanged_date": "December 23, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ansan-si", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do", 
                    "zip": "425-707"
                }, 
                "name": "Department of Endocrinology and Metabolism, Korea University Ansan Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of Nut Consumption on Metabolic Syndrome in Korean Adults - A Randomized Controlled Dietary Intervention Trial", 
        "overall_official": {
            "affiliation": "Department of Endocrinology and Metabolism, Korea University Ansan Hospital", 
            "last_name": "Nan Hee Kim, Prof", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "lipid profiles, body mass index, waist circumference, blood pressure, fasting glucose, insulin, hemoglobin A1c and homeostasis model assessment of insulin resistance", 
                "measure": "metabolic parameters", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "description": "white blood cell count, high-sensitive C-reactive protein, Interleukin-6, adiponectin, serum and urine malondialdehyde, oxidized low-density lipoprotein, vascular cell adhesion molecule (VCAM) and intercellular adhesion molecule (ICAM)", 
                "measure": "inflammation markers", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "description": "EndoPAT index was assessed to evaluate endothelial function by using a finger plethysmograph based on non-invasive peripheral artery tonometry.", 
                "measure": "Endo-peripheral artery tonometry (EndoPAT) index", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02023749"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Korea University", 
            "investigator_full_name": "Nan Hee Kim", 
            "investigator_title": "Prof", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ministry of Food and Drug Safety, Korea", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ministry of Food and Drug Safety, Korea", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}